CV · CIK 0001378325 · FY2025 live · 2025-12-31
CapsoVision, Inc
View as
Model
Classic Z
FY2025
−13.46
Zone
Distress
Prior
—
Market DD
—
1y PD
—
Meridian Rank
5.45
0–100 · Classic Z tape · not a PD
Book standing
6
Year change
—
Market PD
—
O-score
4
Events on this name
Same published rows as Today. Not a live recompute.
MARKET PD UNAVAILABLE
watch · 41
- mertonPd: — → —
−13.46
Z″ −30.12
Score −13.46 · distress below 1.80, grey to 2.99, safe at 3.00 and above.
Classic Z factor contributions
X1 Working capital / assets
Short-term liquidity versus the size of the balance sheet.
0.671.2 × = 0.81X2 Retained earnings / assets
Cushion from years of profits. Share buybacks can push this negative at otherwise healthy firms.
−8.571.4 × = −12.00X3 EBIT / assets
Operating return on assets. Highest weight in the original model.
−1.403.3 × = −4.64X4 Book equity / liabilities
Book equity versus the liability stack. Mega-caps often look greyer here than they would if X4 used market cap.
2.700.6 × = 1.62X5 Sales / assets
Asset turnover — how much revenue the asset base supports.
0.751 × = 0.75
Five-year path
Need two annual 10-Ks to draw a path. The desk will pull this issuer’s filings rather than invent a series.
Overview
rule-v1
CapsoVision, Inc is on classic Z at −13.46 (distress) for FY2025, from an SEC 10-K. Retained earnings / assets is the line that sets the print. This is the first live year on the desk. No market tape loaded. Classic Z was fit on manufacturers; buybacks can send retained earnings negative at otherwise healthy issuers, and X4 is book equity, not market cap.
Book screen Distress; market PD —. Tape not priced — not a single default call.
Market DD · naive Merton
No market tape yet.
Pull a year of closes (Yahoo, Nasdaq if Yahoo is limited) and size equity from Nasdaq cap or EDGAR shares. Distance-to-default and 1-year PD stay blank until then.
Sector peers
Closest Classic Z scores · 12th percentile in Healthcare.
- ANVSDistressAnnovis Bio, Inc.−13.34
- ICCMDistressIceCure Medical Ltd.−13.69
- TNONDistressTenon Medical, Inc.−13.21
- SKYEDistressSkye Bioscience, Inc.−13.77
- NXTCDistressNextCure, Inc.−13.78
- LUCDDistressLucid Diagnostics Inc.−13.06
- BMEADistressBiomea Fusion, Inc.−13.87
- TLSIDistressTriSalus Life Sciences, Inc.−13.93
KPI widgets
Current assets
$17M
Total assets
$18M
Current liabilities
$4M
Total liabilities
$5M
Working capital
$12M
Retained earnings
−$156M
EBIT
−$26M
Total sales
$14M
Book equity
$13M
Accession 0001378325-26-000010. Live rank is the latest 10-K on EDGAR (FY2025, period 2025-12-31). Classic Z is the live score. View as does not rewrite the live rank. X4 is book equity. Pulled 13 Sept 2026.